{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:51:46Z","timestamp":1772761906339,"version":"3.50.1"},"reference-count":30,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2022,6,27]]},"DOI":"10.4274\/tjps.galenos.2021.88655","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T07:52:24Z","timestamp":1633420344000},"page":"314-321","source":"Crossref","is-referenced-by-count":4,"title":["Cytotoxic Effects of Britannin on Acute and Chronic Myeloid Leukemia Cells Through Inducing p21-Mediated Apoptotic Cell Death"],"prefix":"10.4274","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-7329","authenticated-orcid":false,"given":"Hassan","family":"MOHAMMADLOU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-9856","authenticated-orcid":false,"given":"Maryam","family":"HAMZELOO-MOGHADAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0675-9574","authenticated-orcid":false,"given":"Marzieh","family":"MOEINIFARD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-585X","authenticated-orcid":false,"given":"Ahmad","family":"GHAREHBAGHIAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.soncn.2005.04.006","article-title":"Herbal medicine and cancer: an introductory overview","volume":"21","author":"Treasure","year":"2005","unstructured":"1. Treasure J. Herbal medicine and cancer: an introductory overview. Semin Oncol Nurs. 2005;21:177-183.","journal-title":"Semin Oncol Nurs"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.phrs.2009.01.017","article-title":"Natural compounds for cancer treatment and prevention","volume":"59","author":"Nobili","year":"2009","unstructured":"2. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59:365-378.","journal-title":"Pharmacol Res"},{"key":"ref2","unstructured":"3. Safarzadeh E, Sandoghchian Shotorbani S, Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull. 2014;4(Suppl 1):421-427."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-3-14","article-title":"Anticancer effects of curcumin: cycle of life and death","volume":"3","author":"Sa","year":"2008","unstructured":"4. Sa G, Das T. Anticancer effects of curcumin: cycle of life and death. Cell Div. 2008;3:14.","journal-title":"Cell Div"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ygyno.2012.06.034","article-title":"Patient-reported outcomes in relapsed ovarian cancer: results from a randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone","volume":"127","author":"Krasner","year":"2012","unstructured":"5. Krasner CN, Poveda A, Herzog TJ, Vermorken JB, Kaye SB, Nieto A, Claret PL, Park YC, Parekh T, Monk BJ. Patient-reported outcomes in relapsed ovarian cancer: results from a randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone. Gynecol Oncol. 2012;127:161-167.","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.taap.2006.12.025","article-title":"Resveratrol: a review of preclinical studies for human cancer prevention","volume":"224","author":"Athar","year":"2007","unstructured":"6. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224:274-283.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Mashati P, Esmaeili S, Dehghan-Nayeri N, Bashash D, Darvishi M, Gharehbaghian A. Methanolic extract from aerial parts of Artemisia annua L. induces cytotoxicity and enhances vincristine-induced anticancer effect in pre-b acute lymphoblastic leukemia cells. Int J Hematol Oncol Stem Cell Res. 2019;13:132-139.","DOI":"10.18502\/ijhoscr.v13i3.1271"},{"key":"ref7","unstructured":"8. Yazdanpanah S, Esmaeili S, Bashash D, Dehghan Nayeri N, Esfini Farahani M, Gharehbaghian A. Cytotoxic and apoptogenic activity of Bryonia aspera extract on pre-B acute lymphoblastic leukemia cell lines. Int J Hematol Oncol Stem Cell Res. 2018;12:204-212."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/1934578x1200700804","article-title":"Anti-proliferative activity and apoptotic potential of britannin, a sesquiterpene lactone from Inula aucheriana","volume":"7","author":"Moghadam","year":"2012","unstructured":"9. Moghadam MH, Hajimehdipoor H, Saeidnia S, Atoofi A, Shahrestani R, Read RW, Mosaddegh M. Anti-proliferative activity and apoptotic potential of britannin, a sesquiterpene lactone from Inula aucheriana. Nat Prod Commun. 2012;7:979-980.","journal-title":"Nat Prod Commun"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF00568995","article-title":"The structure of britannin-a sesquiterpene lactone from Inula britannica","volume":"7","author":"Chugunov","year":"1971","unstructured":"10. Chugunov PV, Sheichenko VI, Ban'kovskii AI, Rybalko KS. The structure of britannin-a sesquiterpene lactone from Inula britannica. Chem Nat Compd. 1971;7:265-268.","journal-title":"Chem Nat Compd"},{"key":"ref10","unstructured":"11. Bown D. The royal horticultural society. New encyclopedia of herbs and their uses. Dorling Kindersley Limited. 2002, Penguin Company, London."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.biopha.2017.08.025","article-title":"Britannin induces apoptosis through AKT-FOXO1 pathway in human pancreatic cancer cells","volume":"94","author":"Moeinifard","year":"2017","unstructured":"12. Moeinifard M, Hassan ZM, Fallahian F, Hamzeloo-Moghadam M, Taghikhani M. Britannin induces apoptosis through AKT-FOXO1 pathway in human pancreatic cancer cells. Biomed Pharmacother. 2017;94:1101-1110.","journal-title":"Biomed Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4103\/jcrt.JCRT_517_17","article-title":"Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells","volume":"15","author":"Hamzeloo-Moghadam","year":"2019","unstructured":"13. Hamzeloo-Moghadam M, Aghaei M, Abdolmoham Madi MH, Fallahian F. Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells. J Cancer Res Ther. 2019;15:1105-1108.","journal-title":"J Cancer Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.bbrc.2017.12.144","article-title":"The suppressive effects of britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS","volume":"497","author":"Cui","year":"2018","unstructured":"14. Cui YQ, Liu YJ, Zhang F. The suppressive effects of britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS. Biochem Biophys Res Commun. 2018;497:916-923.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1007\/s11033-021-06572-x","article-title":"Britannin, a sesquiterpene lactone induces ROS-dependent apoptosis in NALM-6, REH, and JURKAT cell lines and produces a synergistic effect with vincristine","volume":"48","author":"Mohammadlou","year":"2021","unstructured":"15. Mohammadlou H, Hamzeloo-Moghadam M, Mohammadi MH, Yami A, Gharehbaghian A. Britannin, a sesquiterpene lactone induces ROS-dependent apoptosis in NALM-6, REH, and JURKAT cell lines and produces a synergistic effect with vincristine. Mol Biol Rep. 2021;48:6249-6258.","journal-title":"Mol Biol Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/01635581.2021.1931700","article-title":"Britannin a sesquiterpene lactone from Inula aucheriana exerted an anti-leukemic effect in acute lymphoblastic leukemia (ALL) cells and enhanced the sensitivity of the cells to vincristine","volume":"74","author":"Mohammadlou","year":"2022","unstructured":"16. Mohammadlou H, Hamzeloo-Moghadam M, Yami A, Feizi F, Moeinifard M, Gharehbaghian A. Britannin a sesquiterpene lactone from Inula aucheriana exerted an anti-leukemic effect in acute lymphoblastic leukemia (ALL) cells and enhanced the sensitivity of the cells to vincristine. Nutr Cancer. 2022;74:965-977.","journal-title":"Nutr Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2019001239","article-title":"How I treat acute myeloid leukemia in the era of new drugs","volume":"135","author":"CD","year":"2020","unstructured":"17. DiNardo CD, Wei AH. How I treat acute myeloid leukemia in the era of new drugs. Blood. 2020;135:85-96.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"BJ","year":"2006","unstructured":"18. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA; IRIS Investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408-2417.","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/CCO.0b013e328358f62d","article-title":"Current treatment of acute myeloid leukemia","volume":"24","author":"Roboz","year":"2012","unstructured":"19. Roboz GJ. Current treatment of acute myeloid leukemia. Curr Opin Oncol. 2012;24:711-719.","journal-title":"Curr Opin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.hoc.2009.11.008","article-title":"Acute myeloid leukemia","volume":"24","author":"Rubnitz","year":"2010","unstructured":"20. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2010;24:35-63.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia-advances in biology and new approaches to treatment","volume":"349","author":"JM","year":"2003","unstructured":"21. Goldman JM, Melo JV. Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451-1464.","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1534735416664171","article-title":"Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study","volume":"16","author":"Fleischer","year":"2017","unstructured":"22. Fleischer T, Chang TT, Chiang JH, Sun MF, Yen HR. Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study. Integr Cancer Ther. 2017;16:156-164.","journal-title":"Integr Cancer Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","unstructured":"23. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M. Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood. 2005;105:1717-1723.","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3892\/ijo.2016.3423","article-title":"Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562\/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K\/Akt signaling pathway","volume":"48","author":"Chen","year":"2016","unstructured":"24. Chen JR, Jia XH, Wang H, Yi YJ, Wang JY, Li YJ. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562\/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K\/Akt signaling pathway. Int J Oncol. 2016;48:2063-2070.","journal-title":"Int J Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1159\/000490142","article-title":"The critical role of PTEN\/PI3K\/AKT signaling pathway in shikonin-induced apoptosis and proliferation inhibition of chronic myeloid leukemia","volume":"47","author":"Chen","year":"2018","unstructured":"25. Chen Y, Wang T, Du J, Li Y, Wang X, Zhou Y, Yu X, Fan W, Zhu Q, Tong X, Wang Y. The critical role of PTEN\/PI3K\/AKT signaling pathway in shikonin-induced apoptosis and proliferation inhibition of chronic myeloid leukemia. Cell Physiol Biochem. 2018;47:981-993.","journal-title":"Cell Physiol Biochem"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"153425","DOI":"10.1016\/j.phymed.2020.153425","article-title":"Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1\u03b1 in cancer","volume":"81","author":"Zhang","year":"2021","unstructured":"26. Zhang YF, Zhang ZH, Li MY, Wang JY, Xing Y, Ri M, Jin CH, Xu GH, Piao LX, Zuo HX, Jin HL, Ma J, Jin X. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1\u03b1 in cancer. Phytomedicine. 2021;81:153425.","journal-title":"Phytomedicine"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","article-title":"p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy","volume":"76","author":"El-Deiry","year":"2016","unstructured":"27. El-Deiry WS. p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 2016;76:5189-5191.","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/excr.1999.4644","article-title":"p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells","volume":"253","author":"Kang","year":"1999","unstructured":"28. Kang KH, Kim WH, Choi KH. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res. 1999;253:403-412.","journal-title":"Exp Cell Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1158\/0008-5472.CAN-06-4282","article-title":"p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells","volume":"67","author":"Aneja","year":"2007","unstructured":"29. Aneja R, Ghaleb AM, Zhou J, Yang VW, Joshi HC. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells. Cancer Res. 2007;67:3862-3870.","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1096\/fj.04-2226fje","article-title":"Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate","volume":"19","author":"Hastak","year":"2005","unstructured":"30. Hastak K, Agarwal MK, Mukhtar H, Agarwal ML. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J. 2005;19:789-791.","journal-title":"FASEB J"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:59:21Z","timestamp":1717678761000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2021.88655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,6,27]]},"published-print":{"date-parts":[[2022,6,27]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2021.88655","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"value":"1304-530X","type":"print"},{"value":"2148-6247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]}}}